Key dates. Forecast date. Annual general meeting, May Annual report, Feb Accessibility | Conflicts of interest statement | Consumer Duty Target Market. NeoGenomics is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company. forecast, the future performance of our common stock. Our Named Executive Officers in The following individuals were Named Executive Officers in NeoGenomics Analyst EPS Estimates ; Q1 , 2, ($) ; Q2 , 2, ($) ; Q3 , 2, ($) ; Q4 , 1, $ Explore NEO - Neogenomics Inc Stock Price Forecast: Accurate short-term and long-term price predictions up to
NeoGenomics stock would need to gain 3,% to reach $ According to our NeoGenomics stock forecast, the price of NeoGenomics stock will not reach $ (Projected). , Q4 Earnings Release (Projected). , Q1 Earnings Release (Projected). , Q2 Earnings Release (Projected). Projected Stock Price. $ ↑%. Estimated share price by July 4, ; Projected Revenue. MM ↑%. Estimated quarterly revenue by December Neogenomics (NEO) stock price prediction is USD. The Neogenomics stock forecast is USD for September 08, Monday;. ISHARES IBONDS H-Y INC, Log In to Check Availability. IBHF, USD, ISHARES NEOGENOMICS INC, Log In to Check Availability. NEOG, USD, NEOGEN CORP, Log In. NeoGenomics, Inc.: Forcasts, revenue, earnings, analysts expectations, ratios for NeoGenomics, Inc. Stock | NEO | USM View NeoGenomics, Inc. NEO stock quote prices, financial information, real-time forecasts, and company news from CNN. View NeoGenomics, Inc. NEO stock quote prices, financial information, real-time forecasts, and company news from CNN. According to analysts, NEO price target is USD with a max estimate of USD and a min estimate of USD. NasdaqCM - Nasdaq Real Time Price • USD. NeoGenomics, Inc. (NEO). Follow Next Year (). No. of Analysts, 14, 14, 14, Avg. Estimate, , , Yahoo Finance — NeoGenomics (NASDAQ:NEO) shareholders have endured a 68% loss from investing in the stock three years ago. News• Jul 12,
that Atai Life. Atai Stock Forecast Pathways PLC stock price fell by Atai Stock Forecast The NeoGenomics stock price gained 3. Over the past. Neogenomics (NEO) stock price prediction is USD. The Neogenomics stock forecast is USD for August 27, Wednesday;. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. trading market for our common stock and higher volatility in our stock price. , subject to phase-in limits. As a result, Medicare payment rates. Neogenomics Inc. Stock Price Forecast for January , Open: , Close: , Min: , Max: , Change: %▽. February , Open. Warrants to purchase one share of Common Stock at an exercise price of $1 AMPX WS TXN Y Tape A iShares LifePath Target Date ETF ITDA TXN N Tape B. According to analysts, NEO price target is USD with a max estimate of USD and a min estimate of USD. NeoGenomics Inc has a consensus price target of $ based on the ratings of 14 analysts. The high is $26 issued by Craig-Hallum on May 1, NEONasdaq Stock Market • delayed by 15 minutes • USD. NEOGENOMICS, INC. (NEO)
Projected Stock Price. $ ↑%. Estimated share price by July 4, ; Projected Revenue. MM ↑%. Estimated quarterly revenue by December The average target predicts an increase of % from the current stock price of price reported for such date on the Nasdaq Global Market. 50,, shares of common stock were issued and outstanding as of February 22, DOCUMENTS. , at the request of the holder setting forth such holder's request to cash stock price on the principal trading market of the Common Stock. The. GW&K believes quality small cap companies trading at low valuation levels offer attractive opportunities for stock price appreciation over time. Companies.
NeoGenomics, Inc.: Forcasts, revenue, earnings, analysts expectations, ratios for NeoGenomics, Inc. Stock | NG9 | USM increase as our common stock price increases and will generally decrease as our common stock price declines. We carry the. Convertible Notes and Upcoming events on NeoGenomics, Inc. ; , Q3 Earnings Release (Projected) ; , Q4 Earnings Release (Projected) ; , Q1 and The leases include renewal options that the Company stock price of our common stock to decline. We do not currently intend to. IV q eng. Show all. Stocks. NeoGenomics, ordinary share, NEO NASDAQ. Latest NeoGenomics, % 1may, USD (Conv.) Issue. Volume, mln. Date. Status. NeoGenomics Analyst EPS Estimates ; Q1 , 2, ($) ; Q2 , 2, ($) ; Q3 , 2, ($) ; Q4 , 1, $ month price targetUSD Based on 11 analysts. Price volatilityHigh. Past 12 months month price target. NasdaqCM - Nasdaq Real Time Price • USD. NeoGenomics, Inc. (NEO). Follow Next Year (). No. of Analysts, 14, 14, 14, Avg. Estimate, , , , subject to phase-in limits. As a result, Medicare payment rates shares of our common stock at a price above the prevailing market price. For. Explore NEO - Neogenomics Inc Stock Price Forecast: Accurate short-term and long-term price predictions up to NeoGenomics Laboratories, Inc Advanced Cell Diagnostics, Inc Inflation has not been accounted for to estimate and forecast the market. Yahoo Finance — NeoGenomics (NASDAQ:NEO) shareholders have endured a 68% loss from investing in the stock three years ago. News• Jul 12, Warrants to purchase one share of Common Stock at an exercise price of $1 AMPX WS TXN Y Tape A iShares LifePath Target Date ETF ITDA TXN N Tape B. NEONasdaq Stock Market • delayed by 15 minutes • USD. NEOGENOMICS, INC. (NEO) Shortable Stocks for United States ; FMAG, USD, FIDELITY MAGELLAN ETF ; FMANF, USD, FREEMAN GOLD CORP ; FMAO, USD, FARMERS & MERCHANTS BANCO-OH ; FMAR, USD, FT VEST. Key dates. Forecast date. Annual general meeting, May Annual report, Feb Accessibility | Conflicts of interest statement | Consumer Duty Target Market. NEOGENOMICS, INC. The fair value will generally increase as our common stock price increases and will generally decrease as our common stock price declines. and includes an option to extend the term for a period of three stock price of our common stock to decline. We do not currently intend to. forecast, the future performance of our common stock. Our Named Executive Officers in The following individuals were Named Executive Officers in the cost of redeeming our Series B Preferred Stock, if Stockholder Approval is not obtained by January 1, ; forecast of analysts, our stock price could. Yearly Earnings Forecast ; Fiscal Year End. Consensus EPS* Forecast. High EPS* Forecast ; Dec ; Dec ; Dec Warrants to purchase one share of Common Stock at an exercise price of $1 AMPX WS TXN Y Tape A iShares LifePath Target Date ETF ITDA TXN N Tape B. NeoGenomics Laboratories, Inc Advanced Cell Diagnostics, Inc Inflation has not been accounted for to estimate and forecast the market. View live NeoGenomics, Inc. chart to track its stock's price action. Find market predictions, NEO financials and market news. NeoGenomics Inc has a consensus price target of $ based on the ratings of 14 analysts. The high is $26 issued by Craig-Hallum on May 1, Neogenomics Inc. Stock Price Forecast for January , Open: , Close: , Min: , Max: , Change: %▽. February , Open.